Mechanism of Action
Immune igniter
Alliance
–
Development Stage
Ph1b completed
Preparing for Ph2, third line pancreatic cancer
Clinical Trials (ClinicalTrials.gov)
CBP501, Cisplatin and Nivolumab in Advanced Refractory Tumors
Mechanism of Action
XPO1 reversible inhibitior
Alliance
Development Stage
Ph1 in progress
Clinical Trials(ClinicalTrials.gov)
A Phase 1 Trial of a Novel XPO1 Inhibitor in Patients With Advanced Solid Tumors